| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/19/2006 | US7109233 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 09/19/2006 | US7109232 Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity |
| 09/19/2006 | US7109231 Antiinflammatory agents; sepsis |
| 09/19/2006 | US7109230 Resistance-repellent retroviral protease inhibitors |
| 09/19/2006 | US7109229 Methods and compounds for treating proliferative diseases |
| 09/19/2006 | US7109228 Pyrazole derivatives |
| 09/19/2006 | US7109227 Anticancer agents |
| 09/19/2006 | US7109226 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 09/19/2006 | US7109225 Substituted oxazole derivatives |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109222 Thiazole or oxazole derivatives such as 5-(4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl)-indan-2-carboxylic acid; Hypercholesterolemia, hyperlipidemia, and diabetes |
| 09/19/2006 | US7109220 cyclin dependent kinase (CDK) inhibitors useful in treating or ameliorating a CDK mediated disorder consisting of cervical adenocarcinoma, colon carcinoma and malignant melanoma |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109216 For therapy of psychiatric and neurological disorders |
| 09/19/2006 | US7109215 Compounds possessing neuronal activity |
| 09/19/2006 | US7109214 neuropeptide alpha -calcitonin gene-related peptide antagonists; treatment of pain; headache; asthma; cardiovascular disorders; for reducing morphine tolerance |
| 09/19/2006 | US7109213 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 09/19/2006 | US7109212 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/19/2006 | US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 09/19/2006 | US7109210 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 09/19/2006 | US7109209 Pyrazolopyridines, process for their preparation and use as therapeutic compounds |
| 09/19/2006 | US7109208 Rho kinase inhibitors having axon of the retinal ganglion cellal extension- and optic nerve cell regeneration- promoting action, particularly (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide |
| 09/19/2006 | US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 09/19/2006 | US7109206 Methods and compositions for the rapid and enduring relief of inadequate myocardial function |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109204 Tyrosine kinase inhibitors |
| 09/19/2006 | US7109203 for use in the treatment or prevention of diseases in which bradykinin B1 receptor activation plays a role |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109201 5-HT1D receptor antagonist activity; antidepressants |
| 09/19/2006 | US7109200 Carbamate derivatives, process for producing the same and use thereof |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109198 Method for treating obesity |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109195 Hexacyclic compounds and their therapeutic use |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109193 Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| 09/19/2006 | US7109192 dipeptidylpeptidase-IV inhibitors; treatment of diabetes and obesity |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109190 Carbacephem β-lactam antibiotics |
| 09/19/2006 | US7109189 Mitochondrially targeted antioxidants |
| 09/19/2006 | US7109188 motexafin gadolinium or lutetium for injection in sealed glass vial purged of oxygen; radiation sensitizer acts to catalyze the oxidation of NAD(P)H, ascorbate and other reducing agents |
| 09/19/2006 | US7109187 Estrogenic compounds as anti-mitotic agents |
| 09/19/2006 | US7109186 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 09/19/2006 | US7109185 Pharmaceutical formulations comprising indolinone derivatives |
| 09/19/2006 | US7109184 Phosphate transport inhibitors |
| 09/19/2006 | US7109183 Phosphohalohydrins, process for the production thereof and use thereof |
| 09/19/2006 | US7109182 Synthetic oligomannosides, preparation and uses thereof |
| 09/19/2006 | US7109181 Administering to a subject a purinergic receptor agonist in an amount therapeutically effective to alter the amount or formulation of synovial fluids |
| 09/19/2006 | US7109180 Stimulate mammalian coronary vasodilatation, imaging the heart |
| 09/19/2006 | US7109179 Methods and compositions comprising DNA damaging agents and p53 |
| 09/19/2006 | US7109178 Method for ligating nucleic acids and molecular cloning |
| 09/19/2006 | US7109177 Methods and compositions for the manufacture of C-3′ and C-4′ anthracycline antibiotics |
| 09/19/2006 | US7109176 For therapy of inflammatory diseases and conditions in humans and animals |
| 09/19/2006 | US7109175 saponin-like compounds isolated from Mandevilla species; comprising saponin oligosugar bound to a pregnane-3 beta -ol steroid portion; for decreasing spontaneous cell proliferation |
| 09/19/2006 | US7109174 Anticonvulsant derivatives useful for preventing the development of type II diabetes mellitus and syndrome X |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7109166 A piperazine-somatostatin analog in sustained release ionic conjugate with lactic acid-glycolic acid-tartaric acid copolymer; for therapy of gastrointestinal disorders, such as Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, VIPoma, nesidoblastosis |
| 09/19/2006 | US7109165 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7109163 For use in hemostatic devices that are suitable for applying a flowable hemostatic formulation to a site requiring hemostasis |
| 09/19/2006 | US7109161 Benzethonium chloride in combination with phenoxyethanol; antimicrobial |
| 09/19/2006 | US7109011 Nucleotide sequences coding polypeptide for use in the treatment of infections, pneumonia, toxic shock, brain and rheumatic diseases |
| 09/19/2006 | US7108992 Detecting activated kinase in sample; obtain sample containing kinase, determine phosphorylation state of serine, phosphorylation of preferential serine indicates active state |
| 09/19/2006 | US7108972 Proteins, polynucleotides encoding them and methods of using the same |
| 09/19/2006 | US7108915 Conjugated with an antibody, antigen, enzyme, binding protein, oligonucleotide, polypeptide, or receptor agonist or antagonist; analytical and combinatorial chemistry, medical diagnostics, and genetic analysis |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/19/2006 | US7108870 Process for isolation of withaferin-A from plant materials and products therefrom |
| 09/19/2006 | US7108869 For limiting the absorption of carbohydrates contained in a foodstuff, for promoting weight loss in an individual |
| 09/19/2006 | US7108868 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 09/19/2006 | US7108867 Process for preparing particles |
| 09/19/2006 | US7108866 Chronotherapeutic diltiazem formulations and the administration thereof |
| 09/19/2006 | US7108865 Controlled-release dosage forms of azithromycin |
| 09/19/2006 | US7108864 Non-sustained release combination of a rapidly precipitating drug, a binder, a superdisintegrant, and optionally a lubricant that are mixed and compressed into a tablet without heating, solvent or grinding. |
| 09/19/2006 | US7108862 Enhancing non-anatomic bone formation in a site by administering an HMG-CoA reductase inhibitor to the site |
| 09/19/2006 | US7108861 Environmentally benign crop protection agents |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | US7108845 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 09/19/2006 | US7108844 Use of stabilized oligonucleotides for preparing a medicament with antitumor activity |
| 09/19/2006 | US7108125 Extendable belt conveyor |
| 09/19/2006 | US7107985 Pharmaceutical combination |
| 09/19/2006 | CA2388830C Oral solution containing galanthamine and a sweetening agent |
| 09/19/2006 | CA2309304C Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals |
| 09/19/2006 | CA2292558C 1-amino-alkylcyclohexane nmda receptor antagonists |
| 09/19/2006 | CA2255664C Selenophene anti-tumor agents |
| 09/19/2006 | CA2249240C Indolomorphinan derivative and agent for curing and preventing cerebral disorder |
| 09/19/2006 | CA2248186C Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 09/19/2006 | CA2240845C New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/19/2006 | CA2195079C Aqueous foamable composition |
| 09/19/2006 | CA2154601C Formulations containing coumarins and the use thereof in the pharmaceutical and cosmetic fields |
| 09/19/2006 | CA2149459C Acylated aminoalkanimidazoles and -triazoles |
| 09/19/2006 | CA2140989C Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnosticagent, and a medicament containing them |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/18/2006 | CA2501253A1 Means and methods for individualized drug therapy and for predicting adverse drug reaction |
| 09/15/2006 | CA2500907A1 Vehicle for topical delivery of anti-inflammatory compounds |
| 09/14/2006 | WO2006096861A2 METHODS FOR IDENTIFYING TUMORS RESPONSIVE TO TREATMENT WITH HER DIMERIZATION INHIBITORS (HDIs) |
| 09/14/2006 | WO2006096859A2 THE USE OF THIOPHOSPHONOFORMIC ACID AND NRTIs TO TREAT VIRAL INFECTIONS |
| 09/14/2006 | WO2006096810A2 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0] hexanes |
| 09/14/2006 | WO2006096807A1 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists |